Doctor discusses Ivermectin success in India, questions Canada’s COVID approach
03/12/2021 No Comments
No matter where you stand on how to best handle pandemic policy, Dr. Da Costa’s experience and view is worth a listen.
No matter where you stand on how to best handle pandemic policy, Dr. Da Costa’s experience and view is worth a listen.
Kelly, who is the current member for Hughes in New South Wales, faced a strong backlash from segments of the media and political opponents for sharing information about the anti-malaria drug hydroxychloroquine. Kelly has since appeared at freedom rallies against mandatory vaccinations.
The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”
Recently Merck issued a stern warning that seemed written by marketing, Kory says, “as it had no scientific data to support the conclusion,” that ivermectin was suddenly dangerous. Another pharmaceutical company’s CEO privately noted that “People must think Merck knows what they’re talking about because it’s their drug,” but Merck has “tremendous disincentives” to say nice things about the generic pill, as it has already spent hundreds of millions of dollars developing an oral anti-viral COVID-19 treatment, rival to ivermectin, that may be priced at $3,000 a dose.
They also restricted the use of essential off-label and generic drugs with blatant disinformation campaigns that reminded Kory of big tobacco’s efforts to hide the dangers of smoking. In effect, the public health authorities eliminated the full toolbox of essential scientific methods and drugs that doctors use every day, including the most effective early, prophylactic, and late-stage treatments for COVID-19, which were developed by frontline doctors, not pharmaceutical companies.
In the professor’s continual review of “the latest (and best) literature,” he picked up a surprising “data signal” in October from emerging studies in Latin America. ivermectin, a safe, cheap, FDA-approved anti-parasitic drug, was showing remarkable anti-viral and anti-inflammatory activity as a repurposed drug—the most powerful COVID-19 killer known to science.
Dr. Marik helplessly watched seven covid patients die needlessly after his hospital denied his use of life-saving drugs. He goes to court Thursday for the right to use his judgment to save lives.
An American football quarterback for the Green Bay Packers declared yesterday he was recovering from COVID-19 and had taken a set of medications early
South Africa’s excess mortality trends may shed further light on the efficacy of various interventions. Upon publicly announcing its intentions to secure an HCQ supply, overall excess deaths trended negative, as is often the case following a surge as most surges in excess mortality take place among the most frail who would otherwise make up a substantial portion of those who might have died in upcoming weeks or months. However, excess deaths did not revert particularly sharply after cessation of HCQ usage or upon introduction of vaccines. Each gave way to new waves of mortality.
Dr. Pierre Kory gives a clinic on big pharma’s capture of mainstream media, big tech, medical journals, and governments. “They don’t care if people die.”
In ‘Real Life’ this 10-day Ivermectin Triple Therapy reported here, appears to be a very safe, effective and inexpensive early antiviral treatment for Covid-19. Further detail from the more than 30 doctors involved in treating this patient group, will be used for a formal peer-reviewed publication.
Finally, the AG asks why: “Why would the government want to discourage doctors working with their patients to try to find drugs that can therapeutically heal American citizens, especially when they are more effective and cost-effective?”
According to Zelenko, “HCQ is the safest medication in the history of medicine, azithromycin is one of the most common antibiotics used in medicine, and zinc is a mineral that’s well-known and well-tolerated. These drugs were affordable and available to take at home, which was very important. And they worked.”
The Attorney General provided a detailed, lengthy analysis to the Nebraska HHS lead, declaring that based on the available data, they “do not find clear and convincing evidence that a physician who first obtains informed consent and then utilizes ivermectin or hydroxychloroquine after COVID-19 violates UCA.”
Numerous studies and clinical observation of thousands of patients has indicated that Ivermectin is highly effective in this regard. Even low dose studies that were designed to reach the conclusion that ivermectin was not effective found a signal that indicated that Ivermectin effectively interacted with the COVID virus molecule to prevent or lessen replication of the virus.”
“A Guide to Home-Based COVID Treatment” by the Association of American Physicians and Surgeons includes life-saving best practices for early treatment in an easy-to-understand document for doctors and patients.
We should group all the PrEP, PEP, and early treatment studies of HCQ together at the point at which we see temporal and dose dependent effects time and again. Such research should certainly be separated out, but at the point at which signs of antiviral action emerge so consistently, that observation ties the body of evidence together.
Early on during the pandemic, Singapore adopted a strategy of hospitalizing those showing SARS-CoV-2 symptoms for immediate treatment, rather than waiting for patients to get sicker. Many patients were treated with a variety of medicines, including hydroxychloroquine. During 2020, Singapore boasted one of the best case fatality rates (CFRs) in the world at a mere 0.05%, recording only 29 deaths (5 deaths per million residents), though these statistics may be somewhat generous since Singapore does not count non-pneumonia COVID-19 deaths as COVID-19 deaths. Either Singapore did very well, or the rest of the world dramatically overcounted the COVID-19 impact due to that difference.
Researchers at the MUSC are now conducting clinical trials to help fight against COVID-19, but to settle questions surrounding the drug Ivermectin.
In this tweet, Dr. Robert Malone links here to a page on the globalcovidsummit.org website (in honor of the COVID-19 Summit in Rome) noting that over 3,900 physicians and medical scientists (passed 4,200 now) have signed the Rome Declaration in protest. The declaration was initially passed through the circles of those who attended Rome and gathered in San Juan, but is now open to all physicians and medical scientists. If that includes you, please read it and consider signing.
The May 2021 issue of Antibiotics Review, for example, put out a metanalysis of ivermectin which showed that 100% of 36 prophylaxis and early treatment studies showed positive results, and 26 of the studies showed “statistically significant improvements.”
Australia’s medicine and therapeutic regulatory, the Therapeutic Good Administration (TGA) recently took the gloves off with Ivermectin, the economical anti-parasitic drug associated with at least 63 completed clinical trials involving SARS-CoV-2, the virus behind COVID-19. Now TGA formally places a national prohibition on off-label prescribing of ivermectin to all general practitioners. A comparable move as to what TGA did with hydroxychloroquine in 2020. Clearly further evidence of tightening encroachment of the critically important doctor-patient treatment relationship allowing consent to medical treatment using off-label medications. Of course, this isn’t occurring in a vacuum—it’s part of an unfolding, integrated and what have the signs of a coordinated and orchestrated government action to stop any and all treatments other than those the government declares acceptable.
It does not appear that mass vaccination has yet reduced Costa Rica’s climbing COVID-19 case explosion or mounting death toll.
One such drug is ivermectin, a safe medicine which has been used for nearly 40 years to treat parasitic infections. New evidence show that it has
Concerned about the potential for a more substantial outbreak of the fast-spreading coronavirus, Uganda jumped on the quickly-growing hydroxychloroquine (HCQ) HCQ bandwagon, most often using it as part of a multi-drug regimen in combination with azithromycin, zinc, vitamin C and vitamin D. Through mid-July, Uganda had seen over 1,000 cases of COVID-19 without a single fatality—the largest such “perfect record” in the world at that point in time.
In El Salvador, the Ministry of Public Health has embraced Ivermectin as part of a combination of recommendations for early treatment of COVID-19
There are a number of protocols (sets of prescription and/or OTC meds) for COVID-19. There are prophylactic protocols, which reduce risk of infection. There are sick-at-home protocols, for the milder cases. And there are in-hospital protocols, for the more severe cases.
Risk and benefit analysis suggests if a drug with a well-established, safe profile can help then why wouldn’t such a drug be used?
Dr Stramezzi talks about his experience, his perspectives on treatment of Covid-19, his telemedicine service & the upcoming International Covid Summit in Rome in September.
In Dr. Ozaki’s recent speech, he declared that ivermectin has demonstrated significant benefits in reducing infections and deaths where the regimen is prophylactically administered for another indication. The head of the Metropolitan Medical Association declared that while clinical trials were important, it was time to greenlight doctors to prescribe ivermectin in association with giving the patient informed consent.
This interview with Steve Kirsch features early treatment, vaccination, government responses to pandemics, tech companies & freedom of expression.
Over the past four months, E-BMC Ltd has been working together with the FLCCC to encourage governments around the world to adopt re-purposed existing drugs for the early treatment of
covid-19. One such drug is Ivermectin, a safe medicine which has been used for nearly 40 years to treat parasitic infections. properties as well. E-BMC Ltd’s comprehensive meta-analysis, which has now been published in the peer-reviewed American Journal of Therapeutics, shows that “moderate-certainty evidence” points to a substantial reduction in Covid-19 related deaths with the use of ivermectin.
Dr George Fareed provides an update about the outpatient treatment of COVID-19, for newly infected and for long covid patients.
A victory for Immanuel in court would be a powerful rebuke to the propaganda machine set up to maximize profits for Big Pharma.
Borody’s ivermectin triple therapy prophylactic is the perfect solution. It reduces transmission immediately, regardless of the variant, by preventing the virus from entering a person’s cells. It also shortens time spent in quarantine and reduces transmission to close contacts. Early treatment dramatically reduces hospitalisation and mortality and would rapidly end the Sydney wave, as similar therapies did in Mexico and India. It would also put an end to any need for masks and lockdowns.
The heated debate on the use of Ivermectin to treat COVID-19 continued yesterday when outspoken reggae artiste Tanya Stephens questioned the relevance of not allowing people to decide for themselves what they wish to take to reduce symptoms.
Dr. Safranek aligns his message with groups such as the Front Line COVID-19 Critical Care Alliance (FLCCC) who emphasize the early-onset treatment of the viral disease can make a difference between life and death.
Jamaica’s Minister of Health and Wellness recently signed the import permit to allow stocks of Ivermectin into Jamaica. This comes after rising cases due to the COVID-19 Delta variant and increasing public pressure. Supplies of the generic, anti-parasitic drug will come from Edenbridge Pharmaceuticals in New Jersey and be distributed by LASCO Pharmaceuticals in Jamaica. In general, doctors are pleased about having Ivermectin as an option.
This interview features Dr Caxton Opere, who has not only treated C19 patients but also written 3 books about it, the first one in early April 2020.
The French scientists concluded, “This study supports the use of immunomodulatory drugs such as ivermectin, to improve the clinical condition of SARS-CoV-infected patients.”